252 related articles for article (PubMed ID: 32641979)
21. Utilization of intracellular acylcarnitine pools by mononuclear phagocytes.
Kurth L; Fraker P; Bieber L
Biochim Biophys Acta; 1994 Nov; 1201(2):321-7. PubMed ID: 7947948
[TBL] [Abstract][Full Text] [Related]
22. l-carnitine supplementation during vitrification or warming of in vivo-produced ovine embryos does not affect embryonic survival rates, but alters CrAT and PRDX1 expression.
Saraiva HFRA; Batista RITP; Alfradique VAP; Pinto PHN; Ribeiro LS; Oliveira CS; Souza-Fabjan JMG; Camargo LSA; Fonseca JF; Brandão FZ
Theriogenology; 2018 Jan; 105():150-157. PubMed ID: 28965027
[TBL] [Abstract][Full Text] [Related]
23. Functional studies of yeast-expressed human heart muscle carnitine palmitoyltransferase I.
Zhu H; Shi J; de Vries Y; Arvidson DN; Cregg JM; Woldegiorgis G
Arch Biochem Biophys; 1997 Nov; 347(1):53-61. PubMed ID: 9344464
[TBL] [Abstract][Full Text] [Related]
24. Plasma acylcarnitine levels increase with healthy aging.
Jarrell ZR; Smith MR; Hu X; Orr M; Liu KH; Quyyumi AA; Jones DP; Go YM
Aging (Albany NY); 2020 Jun; 12(13):13555-13570. PubMed ID: 32554854
[TBL] [Abstract][Full Text] [Related]
25. Effect of methylglyoxal bis(guanylhydrazone) on hepatic, heart and skeletal muscle mitochondrial carnitine palmitoyltransferase and beta-oxidation of fatty acids.
Brady LJ; Brady PS; Gandour RD
Biochem Pharmacol; 1987 Feb; 36(4):447-52. PubMed ID: 3827937
[TBL] [Abstract][Full Text] [Related]
26. Medium chain acylcarnitines dominate the metabolite pattern in humans under moderate intensity exercise and support lipid oxidation.
Lehmann R; Zhao X; Weigert C; Simon P; Fehrenbach E; Fritsche J; Machann J; Schick F; Wang J; Hoene M; Schleicher ED; Häring HU; Xu G; Niess AM
PLoS One; 2010 Jul; 5(7):e11519. PubMed ID: 20634953
[TBL] [Abstract][Full Text] [Related]
27. Structural model of carnitine palmitoyltransferase I based on the carnitine acetyltransferase crystal.
Morillas M; López-Viñas E; Valencia A; Serra D; Gómez-Puertas P; Hegardt FG; Asins G
Biochem J; 2004 May; 379(Pt 3):777-84. PubMed ID: 14711372
[TBL] [Abstract][Full Text] [Related]
28. Urinary acylcarnitines are altered in human kidney cancer.
Ganti S; Taylor SL; Kim K; Hoppel CL; Guo L; Yang J; Evans C; Weiss RH
Int J Cancer; 2012 Jun; 130(12):2791-800. PubMed ID: 21732340
[TBL] [Abstract][Full Text] [Related]
29. Carnitine palmitoyl transferase-1A (CPT1A): a new tumor specific target in human breast cancer.
Pucci S; Zonetti MJ; Fisco T; Polidoro C; Bocchinfuso G; Palleschi A; Novelli G; Spagnoli LG; Mazzarelli P
Oncotarget; 2016 Apr; 7(15):19982-96. PubMed ID: 26799588
[TBL] [Abstract][Full Text] [Related]
30. An untargeted analytical workflow based on Kendrick mass defect filtering reveals dysregulations in acylcarnitines in prostate cancer tissue.
Cerrato A; Aita SE; Biancolillo A; Laganà A; Marini F; Montone CM; Rosati D; Salciccia S; Sciarra A; Taglioni E; Capriotti AL
Anal Chim Acta; 2024 Jun; 1307():342574. PubMed ID: 38719419
[TBL] [Abstract][Full Text] [Related]
31. Toxicity of cephaloridine to carnitine transport and fatty acid metabolism in rabbit renal cortical mitochondria: structure-activity relationships.
Tune BM; Hsu CY
J Pharmacol Exp Ther; 1994 Sep; 270(3):873-80. PubMed ID: 7932199
[TBL] [Abstract][Full Text] [Related]
32. Development of a metabolic pathway-based pseudo-targeted metabolomics method using liquid chromatography coupled with mass spectrometry.
Xu J; Li J; Zhang R; He J; Chen Y; Bi N; Song Y; Wang L; Zhan Q; Abliz Z
Talanta; 2019 Jan; 192():160-168. PubMed ID: 30348373
[TBL] [Abstract][Full Text] [Related]
33. Human plasma metabolomics for identifying differential metabolites and predicting molecular subtypes of breast cancer.
Fan Y; Zhou X; Xia TS; Chen Z; Li J; Liu Q; Alolga RN; Chen Y; Lai MD; Li P; Zhu W; Qi LW
Oncotarget; 2016 Mar; 7(9):9925-38. PubMed ID: 26848530
[TBL] [Abstract][Full Text] [Related]
34. Carnitine palmitoyltransferase 1A functions to repress FoxO transcription factors to allow cell cycle progression in ovarian cancer.
Shao H; Mohamed EM; Xu GG; Waters M; Jing K; Ma Y; Zhang Y; Spiegel S; Idowu MO; Fang X
Oncotarget; 2016 Jan; 7(4):3832-46. PubMed ID: 26716645
[TBL] [Abstract][Full Text] [Related]
35. Decreased long-chain acylcarnitines from insufficient β-oxidation as potential early diagnostic markers for Parkinson's disease.
Saiki S; Hatano T; Fujimaki M; Ishikawa KI; Mori A; Oji Y; Okuzumi A; Fukuhara T; Koinuma T; Imamichi Y; Nagumo M; Furuya N; Nojiri S; Amo T; Yamashiro K; Hattori N
Sci Rep; 2017 Aug; 7(1):7328. PubMed ID: 28779141
[TBL] [Abstract][Full Text] [Related]
36. Mutagenesis of specific amino acids converts carnitine acetyltransferase into carnitine palmitoyltransferase.
Cordente AG; López-Viñas E; Vázquez MI; Gómez-Puertas P; Asins G; Serra D; Hegardt FG
Biochemistry; 2006 May; 45(19):6133-41. PubMed ID: 16681386
[TBL] [Abstract][Full Text] [Related]
37. Carnitine acetyltransferase (CRAT) expression in macrophages is dispensable for nutrient stress sensing and inflammation.
Goldberg EL; Dixit VD
Mol Metab; 2017 Feb; 6(2):219-225. PubMed ID: 28180063
[TBL] [Abstract][Full Text] [Related]
38. Dietary l-carnitine stimulates carnitine acyltransferases in the liver of aged rats.
Karlic H; Lohninger S; Koeck T; Lohninger A
J Histochem Cytochem; 2002 Feb; 50(2):205-12. PubMed ID: 11799139
[TBL] [Abstract][Full Text] [Related]
39. Carnitine palmitoyltransferase I, carnitine palmitoyltransferase II, and acyl-CoA oxidase activities in Atlantic salmon (Salmo salar).
Frøyland L; Madsen L; Eckhoff KM; Lie O; Berge RK
Lipids; 1998 Sep; 33(9):923-30. PubMed ID: 9778140
[TBL] [Abstract][Full Text] [Related]
40. Interorgan cooperativity in carnitine metabolism in the trained state.
Lennon DL; Mance MJ
J Appl Physiol (1985); 1986 May; 60(5):1659-64. PubMed ID: 3710984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
